Charles Beever serves as Executive at REXAHN PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Charles Beever has executed 10 insider transactions totaling $31.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 31, 2019 involved purchasing 10,000 shares valued at $6.4K.
Charles Beever currently holds 11,000 shares of REXAHN PHARMACEUTICALS, INC. (RXHN.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Beever has been a net buyer of RXHN.OB stock. They have purchased $31.0K and sold $0 worth of shares.
Charles Beever's most recent insider trade was on Jan 31, 2019, when they purchased 10,000 shares at $0.64 per share.
Get notified when new Form 4 filings are submitted
| $2.25 |
| Discretionary |
| Apr 8, 2008 | RXHN.OB | $1.1K | Purchase | 500 | $2.30 | Discretionary |
| Apr 8, 2008 | RXHN.OB | $1.2K | Purchase | 500 | $2.35 | Discretionary |
| Apr 8, 2008 | RXHN.OB | $4.9K | Purchase | 1,960 | $2.50 | Discretionary |
| Apr 8, 2008 | RXHN.OB | $1.2K | Purchase | 500 | $2.49 | Discretionary |
| Apr 8, 2008 | RXHN.OB | $2.8K | Purchase | 1,178 | $2.40 | Discretionary |
| Apr 8, 2008 | RXHN.OB | $2.5K | Purchase | 1,000 | $2.50 | Discretionary |
| Apr 8, 2008 | RXHN.OB | $8.4K | Purchase | 3,362 | $2.50 | Discretionary |
| Apr 8, 2008 | RXHN.OB | $1.3K | Purchase | 500 | $2.50 | Discretionary |